Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Quinazoline-based anti-virulence compounds selectively target Salmonella PhoP/PhoQ signal transduction system

Thumbnail
Files
Article (3.187Mb)
Self archived version
final draft
Date
2020
Author(s)
Carabajal, María Ayelén
Asquith, Christopher R M
Laitinen, Tuomo
Tizzard, Graham J
Yim, Lucía
Rial, Analía
Chabalgoity, José A
Zuercher, William J
García Véscovi, Eleonora
Unique identifier
10.1128/AAC.01744-19
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Carabajal, María Ayelén. Asquith, Christopher R M. Laitinen, Tuomo. Tizzard, Graham J. Yim, Lucía. Rial, Analía. Chabalgoity, José A. Zuercher, William J. García Véscovi, Eleonora. (2020). Quinazoline-based anti-virulence compounds selectively target Salmonella PhoP/PhoQ signal transduction system.  Antimicrobial agents and chemotherapy, 64 (1) , e01744-19. 10.1128/AAC.01744-19.
Rights
© American Society for Microbiology
Licensed under
All rights reserved
Abstract

The rapid emergence of multidrug resistance among bacterial pathogens has become a significant challenge to human health in our century. Therefore, development of next-generation antibacterial compounds is an urgent need. Two-component signal transduction systems (TCS) are stimulus-response coupling devices that allow bacteria to sense and elaborate adaptive responses to changing environmental conditions, including the challenges that pathogenic bacteria face inside the host. The differential presence of TCS, present in bacteria but absent in the animal kingdom, makes them attractive targets in the search for new antibacterial compounds. In Salmonella enterica, the PhoP/PhoQ two-component system controls the expression of crucial phenotypes that define the ability of the pathogen to establish infection in the host. We now report the screening of 686 compounds from a GlaxoSmithKline published kinase inhibitor set in a high-throughput whole-cell assay that targets Salmonella enterica serovar Typhimurium PhoP/PhoQ. We identified a series of quinazoline compounds that showed selective and potent downregulation of PhoP/PhoQ-activated genes and define structural attributes required for their efficacy. We demonstrate that their bioactivity is due to repression of the PhoQ sensor autokinase activity mediated by interaction with its catalytic domain, acting as competitive inhibitors of ATP binding. While noncytotoxic, the hit molecules exhibit antivirulence effect by blockage of S. Typhimurium intramacrophage replication. Together, these features make these quinazoline compounds stand out as exciting leads to develop a therapeutic intervention to fight salmonellosis.

URI
https://erepo.uef.fi/handle/123456789/7931
Link to the original item
http://dx.doi.org/10.1128/AAC.01744-19
Publisher
American Society for Microbiology
Collections
  • Terveystieteiden tiedekunta [1335]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap